Cardiac Wire #235 December 19, 2024
Challenging CHAGASICS | Merck’s New GLP-1
Cardiac Wire #234 December 16, 2024
Robotic Valve Funding | NHS’ Cardiac Crisis
Cardiac Wire #233 December 12, 2024
Obicetrapib’s Unexpected Outcomes | CV Hospital Costs
Cardiac Wire #232 December 9, 2024
Tirzepatide’s Triumph | Clopidogrel Beats Aspirin
Cardiac Wire #231 December 5, 2024
MariTide’s Weight Loss Milestone | Diabetes’ Early Impact
Cardiac Wire #230 December 2, 2024
Winrevair Wins Again | Boards Are Big Business
Cardiac Wire #229 November 25, 2024
Muvalaplin Aces Lp(a) Test | A New ATTR-CM Option
Cardiac Wire #228 November 21, 2024
AHA 2024 Highlights | First-Line VT Ablation
Cardiac Wire #227 November 18, 2024
Tirzepatide’s Prediabetes Triumph | Valvosoft Hits Endpoints
Cardiac Wire #226 November 14, 2024
The SAFEty of IVC Filters | CKM & CVD
Cardiac Wire #225 November 11, 2024
LimFlow Limits CLTI | J&J’s PFA Play
Cardiac Wire #224 November 7, 2024
Boston Scientific Bolsters AFib Mapping | Hypertension’s Digital Problem
Cardiac Wire #223 November 4, 2024
TCT 2024’s Top TAVR Studies | CCTA’s Big Day
Cardiac Wire #222 October 31, 2024
The Best in Cardiology | Reconsidering Colchicine
Cardiac Wire #221 October 28, 2024
America’s CVD Problem | BAC & CAC Screening
Cardiac Wire #220 October 24, 2024
The State of Cardiology | Oral GLP-1’s CV Potential
Cardiac Wire #219 October 21, 2024
Questioning Semaglutide’s CVD Impact | iCardio Clearance
Cardiac Wire #218 October 17, 2024
AFib Inhaler’s Mixed Results | Spironolactone Spirals
Cardiac Wire #217 October 10, 2024
